You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,846,744


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,846,744
Title:Pharmaceutical compositions of co-crystals of tramadol and coxibs
Abstract: The present invention relates to oral pharmaceutical compositions comprising co-crystals of tramadol and celecoxib and processes for the preparation of these oral pharmaceutical compositions. The present invention also relates to methods of using oral pharmaceutical compositions comprising co-crystals of tramadol and celecoxib as medicaments, more particularly for the treatment of pain.
Inventor(s): Soler Ranzani; Luis (Barcelona, ES), Falivene Aldea; Albert (Barcelona, ES)
Assignee: Laboratorios del Dr. Esteve, S.A. (Barcelona, ES)
Application Number:13/701,192
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property law, providing inventors with exclusive rights to their innovations. The United States Patent and Trademark Office (USPTO) is responsible for granting these patents, and understanding the scope and claims of a patent is essential for both inventors and businesses. This article will delve into the specifics of patent scope, claims, and the broader patent landscape, using U.S. Patent 8,846,744 as a case study.

What is a Patent?

A patent is a grant of exclusive rights to an inventor for a new and useful invention. In the United States, patents are governed by the USPTO and must meet the criteria of being novel, nonobvious, and useful[4].

Determining Inventorship

Before diving into the scope and claims, it's important to understand who can be listed as an inventor. U.S. patent law requires that only the "true and only" inventors be listed on a patent application. This involves identifying those who conceived the idea or subject matter of the patent claims, a process that focuses on the conception step rather than the reduction to practice[2].

Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is a critical aspect of patent quality and can significantly impact innovation and litigation. Two simple metrics for measuring patent scope are independent claim length and independent claim count. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Independent Claim Length and Count

Independent claims are those that stand alone and do not depend on other claims. The length and count of these claims can indicate the scope of the patent. Generally, narrower claims with shorter lengths and fewer counts are associated with a higher probability of grant and a shorter examination process[3].

Patent Claims

Patent claims define the scope of the invention and are the most critical part of a patent application. They must be clear, concise, and supported by the patent's description.

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a device or system.

Drafting Claims

Drafting patent claims is an art that requires precision. Claims must be broad enough to cover the invention but narrow enough to avoid prior art and ensure validity. The examination process often narrows the scope of patent claims to ensure they meet these criteria[3].

Case Study: U.S. Patent 8,846,744

To illustrate these concepts, let's consider U.S. Patent 8,846,744, though the specific details of this patent are not provided here. Here is how the general principles apply:

Identifying the Inventors

The inventors listed on the patent would have been those who conceived the idea or subject matter of the patent claims. Ensuring that only the true inventors are listed is crucial to avoid issues of invalidity or unenforceability[2].

Understanding the Claims

The claims of U.S. Patent 8,846,744 would define the scope of the invention. Independent claims would outline the broadest aspects of the invention, while dependent claims would further limit these to specific embodiments.

Analyzing the Scope

The scope of the patent would be determined by the breadth and depth of its claims. Using metrics such as independent claim length and count, one could assess whether the patent has a narrow or broad scope. A narrower scope might indicate a more focused invention with a higher likelihood of being granted and maintained[3].

The Patent Landscape in the United States

The USPTO plays a central role in the patent landscape, granting over 309,000 utility patents in 2018 alone. Here are some key trends and statistics:

Patent Activity

  • Utility Patents: In 2018, the USPTO awarded 309,000 utility patents, with businesses receiving the majority (85%)[4].
  • Technology Areas: Patents are classified into various technology areas, with electrical and mechanical engineering patents making up about 60% of USPTO patents in 2018[4].

Global Trends

  • International Comparisons: The USPTO data is often compared internationally using the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields[4].

The Role of the USPTO

The USPTO provides several services and tools to facilitate the patent process:

Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, offers public access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist users[1].

Global Dossier

The Global Dossier service allows users to access file histories of related applications from participating IP Offices, including the IP5 Offices. This service helps in identifying patent families, office actions, and other relevant data[1].

Challenges and Considerations

Small Claims Patent Court

There has been discussion about establishing a small claims patent court to address issues related to patent litigation costs and complexity. The Administrative Conference of the United States (ACUS) has conducted studies on the feasibility and structure of such a court[5].

Correcting Errors in Inventorship

Errors in inventorship can be corrected, but deceptive intent can render a patent invalid and unenforceable. Ensuring accurate inventorship is crucial for maintaining the enforceability of a patent[2].

Key Takeaways

  • Accurate Inventorship: Only the true and only inventors should be listed on a patent application.
  • Patent Scope: Metrics such as independent claim length and count can help measure the scope of a patent.
  • Claim Drafting: Claims must be clear, concise, and supported by the patent's description.
  • USPTO Services: The USPTO provides various tools and services to facilitate the patent process.
  • Global Trends: Patents are classified and compared internationally using standardized systems.

FAQs

What is the importance of accurate inventorship in a patent application?

Accurate inventorship is crucial because listing incorrect inventors can lead to the patent being invalid or unenforceable. It is a legal matter, not a collegial or team-building one[2].

How is patent scope measured?

Patent scope can be measured using metrics such as independent claim length and independent claim count. These metrics have explanatory power for several correlates of patent scope[3].

What is the role of the USPTO Public Search Facility?

The USPTO Public Search Facility provides public access to patent and trademark information in various formats, including online, microfilm, and print, with trained staff available to assist users[1].

Why is the Global Dossier service important?

The Global Dossier service allows users to access file histories of related applications from participating IP Offices, helping in identifying patent families, office actions, and other relevant data[1].

What is the proposed small claims patent court?

The proposed small claims patent court is a potential solution to address issues related to patent litigation costs and complexity, with studies conducted by ACUS on its feasibility and structure[5].

Sources

  1. USPTO: Search for patents - USPTO.
  2. Oregon State University: Determining Inventorship for US Patent Applications.
  3. SSRN: Patent Claims and Patent Scope.
  4. NSF: Invention: U.S. and Comparative Global Trends.
  5. ACUS: U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,846,744

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kowa Pharms SEGLENTIS celecoxib; tramadol hydrochloride TABLET;ORAL 213426-001 Oct 15, 2021 DISCN Yes No 8,846,744 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,846,744

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
10384002Jun 4, 2010
PCT Information
PCT FiledJune 03, 2011PCT Application Number:PCT/EP2011/002749
PCT Publication Date:December 08, 2011PCT Publication Number: WO2011/151080

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.